Bremenn Clinical

Vysera-CLS

Serving
1 Capsule(s)
Per container
60
Form
capsule-unknown
UPC
815238010499
DSLD
Formula hash
995b11a00eb2
Brand context
Catalog
1
products
With avoid flag
1
products
FDA recalls
0
history
CAERS
0
reports
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

5 active ingredients
IngredientAmount% DV
Niacin
vitaminUNII · 2679MF687A
3 effects
1.6× ULexceeds NIH ODS adult upper limitsource →
56 mg280%
Calcium
mineralUNII · SY7Q814VUP
UL · set6 effects
36 mg4%
Chromium
mineralUNII · 0R0008Q3JB
1 effect
50 mcg42%
Proprietary Weight Control Component:
Proprietary Blend (Combination)other
142 mg
Proprietary Energy/Focus/Mood Component:
Proprietary Blend (Combination)other
115 mg
What this product supports · authorized claims

9 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Yellow #5
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

  • ◐ CAUTIONFD&C Blue #1
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

Other ingredients

Microcrystalline Cellulose · Gelatin · Magnesium Stearate · Silicon Dioxide · Turmeric